Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Expected FDA approval timeline is late 2026 to early 2027, with Health Canada approval likely following sometime after
We also developed a method of attaching fatty acids to GLP-1 and staying in the body for a long time
Hanmi Pharmaceutical Role & Responsibilities: Hanmi is advancing multi-receptor agonists to address obesity and related metabolic conditions
Back Althage, MC, Ford, EL, Wang, S, et al (27 June 2008) 'Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet', Journal of Biological Chemistry , 283/26, 18365-76
More gentle and stable than alcohol, the perfect ingredient for preserving precious plant nutrients
